SLGL (Sol-Gel Technologies) Future Price to Earnings

Sol-Gel Technologies (SLGL) utilizes proprietary microencapsulation to treat acne, ensuring high profitability. The company's 12-month forward P/E reflects the asset's value relative to expected earnings, with the metric currently standing at 0.00. The business is scaling B2B sales of dermatological products, while a stable cash flow is generated through licensing royalties from global pharmaceutical behemoths.

Forward P/E Multiple: sol-gel.com (SLGL) for 07/04/2022 - 11/11/2026

Sol-Gel Technologies, Ltd. (SLGL) - metric breakdowns and financial figures

- current price and projected stock value:

Stock Quotes Sol-Gel Technologies Ltd.|SLGL - Fair Value Consensus

- business market valuation indicators:

Market Value Sol-Gel Technologies Ltd|SLGL - Company Buyout Price

- balance sheet equity data:

Net Assets per Single Share Sol-Gel Technologies|SLGL - Book Capitalization|Market Capitalization to Book Value Ratio sol-gel.com|SLGL - Company Total Asset Base

- debt and liquidity details:

- company profitability and valuation multiples indicators:

SLGL - Annual Net Income|Projected Future Earnings Sol-Gel Technologies|SLGL - Market Cap to Net Income Ratio|Forward P/E Multiple Sol-Gel|SLGL - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sol-Gel Technologies Ltd|SLGL - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Sol-Gel Technologies|SLGL - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months sol-gel.com|SLGL - Net earnings per one share growth for the current year|Earnings growth forecast for next year Sol-Gel Technologies

Basic company analysis:SLGL Sol-Gel Technologies Ltd.

Signature product of Sol-Gel Technologies

The competitiveness of Sol-Gel Technologies (SLGL) is driven by the effectiveness of patent protection and the volume of royalties from dermatological product sales. The ratio of the current price to expected earnings, illustrated on the company's forward P/E chart, digitizes market expectations for these cash flows, allowing investors to assess the fairness of the asset's value during forecast revisions and determine the risk of undervaluation or overpayment.

Competitors of Sol-Gel Technologies (SLGL)